1. van den Hoogen, F, Khanna, D, Fransen, J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747–1755.
Google Scholar | Crossref | Medline2. Van Den Hoogen, F, Khanna, D, Fransen, J, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European league against rheumatism collaborative initiative. Arthrit Rheumat 2013; 65 (11): 2737–2747.
Google Scholar | Crossref | Medline3. Ranque, B, Mouthon, L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010; 9(5): A311–138.
Google Scholar | Crossref | Medline4. Le Guern, V, Mahr, A, Mouthon, L, et al. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004; 43: 1129–1137
Google Scholar | Crossref | Medline5. Nikpour, M, Stevens, WM, Herrick, AL, et al. Epidemiology of systemic sclerosis. Best Pract Res Clin Rheumatol 2010; 24(6): 857–869.
Google Scholar | Crossref | Medline6. Jaeger, VK, Wirz, EG, Allanore, Y, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS ONE 2016; 11(10): e0163894.
Google Scholar | Crossref7. Perelas, A, Silver, RM, Arrossi, AV, et al. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 2020; 8(3): 304–320.
Google Scholar | Crossref | Medline8. Elhai, M, Meune, C, Boubaya, M, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 2017; 76(11): 1897–1905.
Google Scholar | Crossref | Medline9. Walker, UA, Tyndall, A, Czirják, L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 2007; 66(6): 754–763.
Google Scholar | Crossref | Medline10. Peoples, C, Medsger, TA, Lucas, M, et al. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord 2016; 1: 177–240.
Google Scholar | Medline11. Al-Sheikh, H, Ahmad, Z, Johnson, SR. Ethnic variations in systemic sclerosis disease manifestations, internal organ involvement, and mortality. J Rheumatol 2019; 46(9): 1103–1108.
Google Scholar | Crossref | Medline12. Steelandt, A, Benmostefa, N, Avouac, J, et al. Ethnic influence on the phenotype of French patients with systemic sclerosis. Joint Bone Spine 2020; 88: 105081.
Google Scholar | Crossref | Medline13. Volkmann, ER, Tashkin, DP, Sim, M, et al. Determining progression of scleroderma-related interstitial lung disease. J Scleroderma Relat Disord 2018; 4(1): 62–70.
Google Scholar | SAGE Journals14. Chevreul, K, Brigham, KB, Gandré, C, et al. The economic burden and health-related quality of life associated with systemic sclerosis in France. Scand J Rheumatol 2015; 44(3): 238–246.
Google Scholar | Crossref | Medline15. Rezus, E, Burlui, AM, Gafton, B, et al. A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study. Exp Ther Med 2020; 19(3): 1739–1746.
Google Scholar | Medline16. Allanore, Y, Bozzi, S, Terlinden, A, et al. Health assessment questionnaire-disability index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. Arthritis Res Ther 2020; 22(1): 257.
Google Scholar | Crossref | Medline17. Saketkoo, LA, Scholand, MB, Lammi, MR, et al. Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials. J Scleroderma Relat Disord 2020; 5(2 Suppl): 48–60.
Google Scholar | SAGE Journals18. Azuma, A, Chung, L, Behera, D, et al. Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: subgroup analysis of the SENSCIS trial. Respir Investig 2020; 59: 252–259.
Google Scholar | Crossref | Medline19. Herdman, M, Gudex, C, Lloyd, A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20(10): 1727–1736.
Google Scholar | Crossref | Medline20. https://www.has-sante.fr/upload/docs/application/pdf/2018-10/note_de_synthese_place_de_la_qualite_de_vie.pdf
Google Scholar21. Patel, AS, Siegert, RJ, Brignall, K, et al. The development and validation of the King’s brief interstitial lung disease (K-BILD) health status questionnaire. Thorax 2012; 67(9): 804–810.
Google Scholar | Crossref | Medline22. Frantz, C, Avouac, J, Distler, O, et al. Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey. Semin Arthritis Rheum 2016; 46(1): 115–123.
Google Scholar | Crossref | Medline23. Hudson, M, Thombs, BD, Steele, R, et al. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009; 61(8): 1112–1120.
Google Scholar | Crossref | Medline24. van Hout, B, Janssen, MF, Feng, YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012; 15(5): 708–715.
Google Scholar | Crossref | Medline25. Andrade, LF, Ludwig, K, Goni, JMR, et al. A French value set for the EQ-5D-5L. Pharmacoeconomics 2020; 38(4): 413–425
Google Scholar | Crossref | Medline26. Schioppo, T, Scalone, L, Cozzolino, P, et al. Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens. Reumatismo 2019; 71(2): 62–67.
Google Scholar | Crossref | Medline27. Mugii, N, Someya, F, Noto, S, et al. Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients. Mod Rheumatol 2020; 30(4): 681–686
Google Scholar | Crossref | Medline28. Nihtyanova, SI, Sari, A, Harvey, JC, et al. Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis. Arthritis Rheumatol 2020; 72(3): 465–476.
Google Scholar | Crossref | Medline29. Durheim, MT, Hoffmann-Vold, AM, Eagan, TM, et al. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF. BMJ Open Respir Res 2020; 7(1): e000598.
Google Scholar | Crossref | Medline30. Flaherty, KR, Wells, AU, Cottin, V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 2019; 381(18): 1718–1727.
Google Scholar | Crossref | Medline31. Ciaffi, J, van Leeuwen, NM, Liem, SIE, et al. Lung function is associated with minimal EQ-5D changes over time in patients with systemic sclerosis. Clin Rheumatol 2020; 39(5): 1543–1549.
Google Scholar | Crossref | Medline32. Ramalho, SHR, Shah, AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med 2021; 31: 93–98.
Google Scholar | Crossref | Medline33. Canoy, D, Luben, R, Welch, A, et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 2004; 159(12): 1140–1149.
Google Scholar | Crossref | Medline34. Park, EH, Strand, V, Oh, YJ, et al. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019; 21: 61.
Google Scholar | Crossref | Medline35. Matucci-Cerinic, M, Kahaleh, B, Wigley, FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013; 65(8): 1953–1962.
Google Scholar | Crossref | Medline36. Bijsterbosch, J, Scharloo, M, Visser, AW, et al. Illness perceptions in patients with osteoarthritis: change over time and association with disability. Arthritis Care Res 2009; 61(8): 1054–1061.
Google Scholar | Crossref37. Fortune, DG, Richards, HL, Griffiths, CEM, et al. Psychological stress, distress and disability in patients with psoriasis: Consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41(Pt2): 157–174.
Google Scholar | Crossref | Medline38. Arat, S, Verschueren, P, De Langhe, E, et al. The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory study. Musculoskeletal Care 2012; 10(1): 18–28.
Google Scholar | Crossref | Medline39. Richards, HL, Herrick, AL, Griffin, K, et al. Systemic sclerosis: patients’ perceptions of their condition. Arthritis Care Res 2003; 49(5): 689–696.
Google Scholar | Crossref